A Virtual Forum Designed to Address Clinical Challenges with the Goal to Improve Patient Outcomes

March 17, 2022 – March 19, 2022

Virtual

 

swoosh
swoosh

AGENDA

ENHANCE YOUR EXPERIENCE WITH MEDCHALLENGE!

This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!

Callout Info for program

PART I

PART II

LEARNING OBJECTIVES

Upon completion of this session, learners will have

  • Increased knowledge regarding the 
    • Clinical trial data evaluating targeted therapies for patients with non-small cell lung cancer (NSCLC) 
  • Greater competence related to  
    • Utilizing diagnostic methodologies to identify molecular alterations in patients with NSCLC
    • Personalizing therapy for patients with NSCLC and molecular alterations
    • Mitigating trAEs in patients receiving targeted therapy for NSCLC
  • Greater confidence in their ability to communicate treatment considerations with patients with NSCLC and molecular alterations as a member of the interprofessional team

    MODERATOR


     

    Learning Objectives

    Upon completion of this session, learners will have

    • Increased knowledge regarding
      • the Clinical trial data evaluating targeted therapies for patients with NSCLC and resistance to therapy
    • Greater competence related to  
      • Personalizing therapy for patients with NSCLC and certain molecular alterations 
      • The use of systemic therapy in patients with advanced NSCLC with CNS metastases
    • Greater confidence in their ability to communicate treatment considerations with patients with NSCLC and molecular alterations as a member of the interprofessional team

       

    MODERATOR


     

    Learning Objectives

    Upon completion of this session, learners will have

    • Increased knowledge regarding the
      • Clinical trial data evaluating immunotherapy as treatment for patients with NSCLC
    • Greater competence related to
      • Selecting the most appropriate immunotherapy-containing regimen for a patient with NSCLC
      • Managing immune-related adverse events in patients receiving immunotherapy for NSCLC
    • Greater confidence in their ability to
      • Communicate treatment considerations with the interprofessional team 

    MODERATOR


     

    Learning Objectives

    Upon completion of this session, learners will have

    • Increased knowledge regarding the  
      • Clinical trial data evaluating regimens used to treat patients with SCLC
      • Evidence for radiation therapy in the management of patients with SCLC
    • Greater competence related to  
      • Identifying potential treatment-related adverse events in patients receiving therapy for SCLC
    • Greater confidence in their ability to
      • Leverage the use of the multidisciplinary team to optimize outcomes in patients with SCLC

    MODERATOR


     

    Learning Objectives

     Upon completion of this session, learners will have

    • Increased knowledge regarding the  
      • Clinical trial data evaluating immunotherapy strategies for patients with mesothelioma
      • Clinical trial data investigating emerging targeted therapeutic strategies
    • Greater confidence in their ability to
      • Effectively communicate aspects of care with mesothelioma patients as a part of the multidisciplinary team

    MODERATOR


     

    Learning Objectives

    Upon completion of this session, learners will have

    • Increased knowledge regarding the
      • Rationale for systemic therapy in patients with early-stage and locally advanced NSCLC
      • Complimentary roles of surgery, radiotherapy, and systemic therapy in early-stage and locally advanced NSCLC
      • Key data from clinical trials evaluating systemic treatment in patients with early-stage and locally advanced NSCLC
    • Greater confidence in their ability to
      • Collaborate as a member of the interprofessional team to manage patients with early-stage and locally advanced NSCLC

    MODERATOR


     

    Learning Objectives

    Upon completion of this session, learners will have

    • Increased knowledge regarding the
      • Importance of early lung cancer detection and screening
      • Clinical trial data evaluating screening and early detection methods
    • Greater confidence in
      • Their ability to incorporate strategies into clinical practice that may improve early detection of lung cancer as a member of the interprofessional team
      • Their ability to identify optimal approaches to patient care

    MODERATOR


     

    Learning Objectives

    Upon completion of this session, learners will have

    • Greater confidence in
      • Their ability to identify optimal approaches to patient care
      • Their ability to discuss approaches to challenging clinical lung cancer cases as part of the interprofessional team

    MODERATOR